Previous close | 85.36 |
Open | 85.36 |
Bid | 69.60 |
Ask | 74.40 |
Strike | 280.00 |
Expiry date | 2025-01-17 |
Day's range | 85.36 - 85.36 |
Contract range | N/A |
Volume | |
Open interest | 42 |
TEMPE, Ariz., April 24, 2024--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the first quarter ("Q1'24"). Q1'24 total revenues were $997.4 million, up 4.3% sequentially and up 5.8% year-over-year. Q1'24 Clear Aligner revenues were $817.3 milli
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
Get a deeper insight into the potential performance of Align Technology (ALGN) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.